In the BioHarmony Drug Report Database
Propantheline
Pro-banthine (propantheline) is a small molecule pharmaceutical. Propantheline was first approved as Pro-banthine on 1982-01-01. It is used to treat irritable bowel syndrome, pancreatitis, peptic ulcer, spasm, and urethral diseases amongst others in the USA. The pharmaceutical is active against muscarinic acetylcholine receptor M2, muscarinic acetylcholine receptor M1, and muscarinic acetylcholine receptor M3. In addition, it is known to target muscarinic acetylcholine receptor M4.
Trade Name
|
Pro-banthine |
|---|---|
Common Name
|
propantheline |
ChEMBL ID
|
CHEMBL1180725 |
Indication
|
irritable bowel syndrome, pancreatitis, peptic ulcer, spasm, urethral diseases, urinary bladder diseases |
Drug Class
|
Image (chem structure or protein)